An2 Therapeutics, Inc. - ANTX

  1. All Sectors
  2. Manufacturing
  3. Chemicals
  4. Pharmaceutical Preparations
Latest data: 4/4/2025 10:40:59 PM
EDGAR CIK 0001880438

Buy Breakdown

Total $27,846

Sell Breakdown

Total $23,610

Monthly Totals

Transaction Filed Name Type Shares @ Price Value Balance change Ownership
01/03/2025
01/07/2025
Chanda Sanjay
Chief Development Officer
Officer
Sell
-2,957 @ $1.34
($3,965.34)
 29,824 (-9.02%) Direct
01/03/2025
01/07/2025
Day Lucy
Chief Financial Officer
CFO
Sell
-2,957 @ $1.34
($3,965.34)
 32,670 (-8.30%) Direct
01/03/2025
01/07/2025
Eizen Joshua M
Chief Operating Officer and Chief Legal Officer
Officer
Sell
-9,663 @ $1.34
($12,958.08)
 116,672 (-7.65%) Direct
01/03/2025
01/07/2025
Prior Stephen David
Chief Strategy Officer
Officer
Sell
-2,029 @ $1.34
($2,720.89)
 33,313 (-5.74%) Direct
11/27/2024
11/27/2024
Zakrzewski Joseph S
Director
Buy
2,000 @ $1.40
$2,800.00
 125,199 (1.62%) Direct
11/19/2024
11/20/2024
Zakrzewski Joseph S
Director
Buy
5,000 @ $1.01
$5,050.00
 123,199 (4.23%) Direct
11/18/2024
11/20/2024
Zakrzewski Joseph S
Director
Buy
20,000 @ $1.00
$19,996.00
 118,199 (20.37%) Direct